# Neurostimulation to Improve NOWS Outcomes

> **NCT05129020** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Spark Biomedical, Inc.** · enrollment: 52 (actual)

## Conditions studied

- Neonatal Opioid Withdrawal Syndrome
- Neonatal Abstinence Syndrome

## Interventions

- **DEVICE:** Sparrow Fledging Therapy System
- **DEVICE:** Sham Sparrow Fledging Therapy System

## Key facts

- **NCT ID:** NCT05129020
- **Lead sponsor:** Spark Biomedical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-07-27
- **Primary completion:** 2025-01-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05129020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05129020, "Neurostimulation to Improve NOWS Outcomes". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05129020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*